On November 28, 2025, Vistagen Therapeutics, Inc. appointed Nick B. Tressler as the Chief Financial Officer and Treasurer, effective December 1, 2025. Tressler's starting salary is $450,000, along with a $50,000 signing bonus and stock options for 150,000 shares at an exercise price of $4.43 per share.